HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1856357Generated: November 2, 2026
Dimethyl Ether → 2-(4-Oxoazetidin-2-yl)ethyl acetate
https://huagongshe.com/reaction/1856357
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethyl Ether | HCID 8254 | — |
| Reactant | 1,3-Butadienyl acetate | HCID 15195 | — |
| Reactant | Chlorosulfonyl isocyanate | HCID 70918 | — |
| Product | 2-(4-Oxoazetidin-2-yl)ethyl acetate | HCID 12769225 | — |
| Product | 2-(4-Oxoazetidin-2-yl)ethenyl acetate | HCID 54177934 | — |
Reaction Steps
In words relative to the above diagram for the preparation of 1, the 4-(2-acetoxyvinyl)azetidine-2-one (3) is prepared by reacting chloro sulphonyl isocyanate and an acyloxybutadiene such as 1-acetoxybutadiene in a solvent such as anhydrous dimethyl ether at a temperature of from about -30° C. to 0° C. under a nitrogen atmosphere. The reaction intermediate 2 is converted to 3 by hydrolysis. The reduction of 3 to provide the 4-(2-acetoxyethyl)-2-azetidinone (4) is conducted by any convenient means such as hydrogenation in the presence of a catalyst such as platinum, palladium or oxides thereof under a hydrogen pressure of from 1 to 20 atmospheres in a solvent such as ethanol, ethylacetate, or the like at a temperature of from 0° to 25° C., for from 5 minutes to 1 hour. The 4-(2-hydroxyethyl)-2-azetidinone species, 5, is obtained from 4 by hydrolysis. The 8-oxo- 2,2-dimethyl-3-oxa-1-azabicyclo[4.2.0]octane species, 6, is obtained on treatment of 5 with 2,2-dimethoxypropane in the presence of a catalyst such as boron trifluoride etherate in a solvent such as methylene chloride at a temperature of from 0° to 40° C. for from 1 to 40 minutes. The azide intermediate 7 is prepared by treating 6 in a solvent such as tetrahydrofuran (THF), dimethoxyethane, dioxane, DMF or the like with a base such as lithium diisopropylamide, butyl lithium, phenyl lithium or the like at a temperature of from -25° to -78° C. for from one to three hours; whereupon an azide reagent such as tosylazide is introduced; after 1 to 3 hours at -35° to -50° C. the mixture is treated with a disproportionating agent such as trimethylchlorosilane to provide the azide 7 which may be isolated. The amino intermediate 8 is prepared by reducing 7 in a solvent such as ethylacetate, ethanol, dioxane, methanol or the like in the presence of a hydrogenation catalyst such as Pd on carbon, PtO2, Pd/CaCO3, or the like and hydrogen (4 to 50 atmospheres) for from 12 to 48 hours at a temperature of from 20° to 30° C. The N-acyl intermediate 8a is obtained from 8 on treatment in a solvent such as CH2Cl2, ether, chloroform or the like with the acid chloride of choice calculated to provide the acyl radical R1 at a temperature of from -25° to 0° C. for from 2 to 15 hours. Species 9 is obtained from 8a by acid hydrolysis.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04218459 |
|---|
| Source dataset | uspto-grants-1980_08 |
|---|
| ORD ID | ord-d0d6e665ad1e401281d1bfe0f5baf166 |
|---|
| Source note | uspto-grants-1980_08 |
|---|